#6 - Kenvue (NYSE:KVUE)
Kenvue Inc. (NYSE: KVUE) is a solid choice for investors looking for a consumer staples stock that also offers an attractive dividend yield. Consumer staples stocks are defensive in nature, which means that consumers will seek out these companies' products regardless of economic conditions.
Kenvue is the consumer products spinoff from Johnson & Johnson (NYSE: JNJ), and it continues to house iconic brands such as Tylenol, Motrin, Benadryl, Listerine, and Neutrogena. The company operates in three core areas: Self Care, Skin Health and Beauty, and Essential Health.
A benefit of being a spinoff is that Kenvue benefits from Dividend King J&J’s legacy of dividend reliability. Kenvue's dividend is around 3.5%.
About Kenvue
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
More about Kenvue- Current Price
- $21.73
- Consensus Rating
- Hold
- Ratings Breakdown
- 5 Buy Ratings, 7 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $25.33 (16.6% Upside)
